Literature DB >> 7598244

Carbon monoxide generation in carbon dioxide absorbents.

J Baum1, G Sachs, C vd Driesch, H G Stanke.   

Abstract

Several cases of unexpected high carboxyhemoglobin (COHb) levels in patients undergoing general anesthesia were observed. To avoid carbon monoxide (CO) intoxication, the use of high fresh gas flows and frequent changes of the absorbent were recommended. However, due to economic and ecologic considerations, low-flow anesthetic techniques have advantages. Thus, the subject urgently needed to be reexamined. In 1001 patients undergoing enflurane or isoflurane anesthesia, blood samples were taken 30 min after fresh gas flow reduction to 0.5 L/min and analyzed for COHb. The absorbent canisters, containing soda lime, were used for several days. The statistical mean and SD of COHb was 1.17% +/- 0.97% in the range of 0%-7.6%. There was no statistical difference between the COHb values when broken down by the duration of use of the absorbent canisters. In no case were dangerously high COHb levels observed. As recently revealed, only dry absorbents produce CO if exposed to volatile anesthetics containing a CHF2-moiety. Thus, all measures must be avoided that dry out the absorbent. Low-flow anesthesia preserves the moisture content of the absorbent and, thus, seems to be a factor protecting from CO generation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598244     DOI: 10.1097/00000539-199507000-00029

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  [Low-flow anesthesia with desflurane].

Authors:  J Baum; M Berghoff; H G Stanke; M Petermeyer; G Kalff
Journal:  Anaesthesist       Date:  1997-04       Impact factor: 1.041

2.  The safety and efficacy of minimal-flow desflurane anesthesia during prolonged laparoscopic surgery.

Authors:  Sang Yoong Park; Chan Jong Chung; Jung Hoon Jang; Jae Young Bae; So Ron Choi
Journal:  Korean J Anesthesiol       Date:  2012-12-14

Review 3.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 4.  Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative Diseases.

Authors:  Anshuman Singh; Shubham Upadhayay; Sidharth Mehan
Journal:  Neurotox Res       Date:  2021-08-25       Impact factor: 3.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.